GPN-Star variant effect prediction benchmarks (Ye et al. 2026)
The authors' variant effect benchmarks for GPN-Star: ClinVar, COSMIC and ProteinGym missense tasks, OMIM, HGMD and fine-mapped UK Biobank coding and non-coding variant tasks, gnomAD rare versus common enrichment, complex trait heritability and rare variant association testing.
Results are recorded on the linked protocols, tasks or configurations listed below. Their settings and evaluations are kept separate.
Overview
An explanatory profile has not yet been reviewed for this record.
Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.
Results on linked records
This benchmark has no results of its own in this release. 10 linked records have results. They are not assigned to the underlying benchmark: each record keeps its own settings and evaluations, and its scores are on its own page.
- ClinVar pathogenic vs benign missense, AUPRC (GPN-Star Supplementary Table 3) Protocol · part of this benchmark · 8 evaluations · 8 results
- COSMIC frequent vs gnomAD common missense, AUPRC (GPN-Star Supplementary Table 3) Protocol · part of this benchmark · 8 evaluations · 8 results
- UK Biobank fine-mapped coding variants, AUPRC (GPN-Star Supplementary Table 3) Protocol · part of this benchmark · 8 evaluations · 8 results
- UK Biobank fine-mapped non-coding variants, AUPRC (GPN-Star Supplementary Table 3) Protocol · part of this benchmark · 8 evaluations · 8 results
- HGMD pathogenic vs gnomAD common regulatory variants, AUPRC (GPN-Star Supplementary Table 3) Protocol · part of this benchmark · 8 evaluations · 8 results
- OMIM pathogenic vs gnomAD common regulatory variants, AUPRC (GPN-Star Supplementary Table 3) Protocol · part of this benchmark · 8 evaluations · 8 results
- ProteinGym human deep mutational scanning, mean Spearman (GPN-Star Supplementary Table 3) Protocol · part of this benchmark · 8 evaluations · 8 results
- gnomAD rare versus common enrichment in the deleterious tail, odds ratio (GPN-Star Fig. 4b) Protocol · part of this benchmark · 12 evaluations · 12 results
- DeepRVAT rare variant association testing, replicated genes (GPN-Star Fig. 2j) Protocol · part of this benchmark · 2 evaluations · 2 results
- DeepRVAT rare variant association testing, significant genes (GPN-Star Fig. 2j) Protocol · part of this benchmark · 2 evaluations · 2 results
Methods and evaluation design
Procedure, tasks and evaluated configurations
Additional methodological details, tasks and evaluated configurations have not yet been extracted into a structured profile for this benchmark. Consult the linked sources and evaluation records below.
Baseline coverage
Reference methods help show what a model adds beyond simple controls. We track a null control and a conventional method for each protocol.
0 of 20 active baseline roles have published Rewire measurements in this release. Measurements on a selected protocol do not establish coverage of an entire suite.
Baseline status by linked protocol
- ClinVar pathogenic vs benign missense, AUPRC (GPN-Star Supplementary Table 3) · 0/2 roles measured
- COSMIC frequent vs gnomAD common missense, AUPRC (GPN-Star Supplementary Table 3) · 0/2 roles measured
- UK Biobank fine-mapped coding variants, AUPRC (GPN-Star Supplementary Table 3) · 0/2 roles measured
- UK Biobank fine-mapped non-coding variants, AUPRC (GPN-Star Supplementary Table 3) · 0/2 roles measured
- HGMD pathogenic vs gnomAD common regulatory variants, AUPRC (GPN-Star Supplementary Table 3) · 0/2 roles measured
- OMIM pathogenic vs gnomAD common regulatory variants, AUPRC (GPN-Star Supplementary Table 3) · 0/2 roles measured
- ProteinGym human deep mutational scanning, mean Spearman (GPN-Star Supplementary Table 3) · 0/2 roles measured
- gnomAD rare versus common enrichment in the deleterious tail, odds ratio (GPN-Star Fig. 4b) · 0/2 roles measured
- DeepRVAT rare variant association testing, replicated genes (GPN-Star Fig. 2j) · 0/2 roles measured
- DeepRVAT rare variant association testing, significant genes (GPN-Star Fig. 2j) · 0/2 roles measured
Protocol coverage CSV (gzip) · Model evaluation matrix (gzip) · Source table (gzip) · Release and checksums (gzip)
Coverage is derived from release 2026-11-21-c8bea25e5abb. Source citations describe the original records; they do not validate an unreviewed baseline proposal. No results have been generated by this audit.
Run instructions
No runnable recipe has been reviewed for this benchmark. Dataset access, model requirements, licences and compute requirements must be checked against its sources before execution.
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
0 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|
No evidence rows match these filters. Choose another scope or clear the search.
Sources and history
Release 2026-11-21-c8bea25e5abb · Record review: source checked
2 source records and release history
- Ye et al. 2026, Predicting genome-wide functional constraints with GPN-Star (Nature) · Original source · Version of record: Nature 659, 141-150 (5 November 2026); received 2025-09-10, accepted 2026-08-07, published online 2026-09-09
- Ye et al. 2026 GPN-Star, Nature Supplementary Information · Original source · Supplementary Information PDF (MOESM1) of the version of record, 57 pages
Technical metadata and record identifiers
Technical metadata for this record is tracked under stable ID gpn-star-20261116-benchmark-gpn-star-vep.
Source locator: Supplementary Information, Evaluation Benchmarks (PDF pages 11-14); Figs. 2-5; Results
Related records
- subject: benchmark_dataset_provenance: gpn-star-20261116-benchmark-gpn-star-vep
- subject: printed_values_scope: gpn-star-20261116-benchmark-gpn-star-vep
- part of: ClinVar pathogenic vs benign missense, AUPRC (GPN-Star Supplementary Table 3)
- part of: COSMIC frequent vs gnomAD common missense, AUPRC (GPN-Star Supplementary Table 3)
- part of: UK Biobank fine-mapped coding variants, AUPRC (GPN-Star Supplementary Table 3)
- part of: UK Biobank fine-mapped non-coding variants, AUPRC (GPN-Star Supplementary Table 3)
- part of: HGMD pathogenic vs gnomAD common regulatory variants, AUPRC (GPN-Star Supplementary Table 3)
- part of: OMIM pathogenic vs gnomAD common regulatory variants, AUPRC (GPN-Star Supplementary Table 3)
- part of: ProteinGym human deep mutational scanning, mean Spearman (GPN-Star Supplementary Table 3)
- part of: gnomAD rare versus common enrichment in the deleterious tail, odds ratio (GPN-Star Fig. 4b)
- part of: DeepRVAT rare variant association testing, replicated genes (GPN-Star Fig. 2j)
- part of: DeepRVAT rare variant association testing, significant genes (GPN-Star Fig. 2j)